Neurobiology of Aging
Volume 27, Issue 7 , Pages 983-993 , July 2006

Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration

  • Janos Feher

      Affiliations

    • Opthalmic Neuroscience Program, Department of Ophthalmology, University of Rome “La Sapienza”, Via Lombardia, 23/c, 00187 Rome, Italy
    • Corresponding Author InformationCorresponding author at. Via Sardegna 139, 00187 Rome, Italy. Tel.: +39 306 4201 0510; fax: +39 306 4201 0510.
    • ,
  • Illes Kovacs

      Affiliations

    • Opthalmic Neuroscience Program, Department of Ophthalmology, Semmelweis University, Budapest, Hungary
    • ,
  • Marco Artico

      Affiliations

    • Opthalmic Neuroscience Program, Department of Human Anatomy, Faculty of Pharmacy, University of Rome “La Sapienza”, Rome, Italy
    • ,
  • Carlo Cavallotti

      Affiliations

    • Opthalmic Neuroscience Program, Department of Cardiovascular and Respiratory Sciences, University of Rome “La Sapienza”, Rome, Italy
    • ,
  • Antonio Papale

      Affiliations

    • Opthalmic Neuroscience Program, Department of Ophthalmology, University of Rome “La Sapienza”, Via Lombardia, 23/c, 00187 Rome, Italy
    • ,
  • Corrado Balacco Gabrieli

      Affiliations

    • Opthalmic Neuroscience Program, Department of Ophthalmology, University of Rome “La Sapienza”, Via Lombardia, 23/c, 00187 Rome, Italy

Received 12 December 2004 ,Revised 8 May 2005 ,Accepted 19 May 2005.

References 

  1. Andrews RM, Griffiths PG, Johnson MA, Turnbull DM. Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina. Br J Ophthalmol. 1999;83:231–235
  2. Atamna H, Ames BN, Liu J. Delaying aging with mitochondrial micronutrients and antioxidants. Sci World J. 2001;1(Suppl 3):81–82
  3. Barron MJ, Johnson MA, Andrews RM, Clarke MP, Griffiths PG, Bristow E, et al. Mitochondrial abnormalities in aging macular photoreceptors. Invest Ophthalmol Vis Sci. 2001;42:3016–3022
  4. Barreau E, Brossas JY, Courtois Y, Treton JA. Accumulation of mitochondrial DNA deletions in human retina during aging. Invest Ophthalmol Vis Sci. 1996;37:384–391
  5. Battelli D, Bellei M, Arrigoni-Martelli E, Muscatello U, Bobyleva V. Interaction of carnitine with mitochondrial cardiolipin. Biochim Biophys Acta. 1992;1117(1):33–3621
  6. Beaumont K, Skowronski R, Vaughn DA, Fanestil DD. Interactions of lipids with peripheral-type benzodiazepine receptors. Biochem Pharmacol. 1988;37(6):1009–101415
  7. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115–134
  8. Ben-Shachar D. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem. 2002;83:1241–1251
  9. Bergmann M, Schutt F, Holz FG, Kopitz J. Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J. 2004;18:562–564
  10. Binienda Z, Virmani A. The mitochondriotropic effects of l-carnitine and its esters in the central nervous system. Curr Med Chem Central Nervous Syst Agents. 2003;3:275–282
  11. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367–374
  12. Bird AC. The Bowman lecture. Towards an understanding of age-related macular disease. Eye. 2003;17:457–466
  13. Brunk UT, Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem. 2002;269:1996–2002
  14. Campbell AM, Capuano A, Chan SH. A cholesterol-binding and transporting protein from rat liver mitochondria. Biochim Biophys Acta. 2002;1567:123–132
  15. Cotman CW, Head E, Muggenburg BA, Zicker S, Milgram NW. Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction. Neurobiol Aging. 2002;23:809–818
  16. Crompton M. Mitochondria and aging: a role for the permeability transition. Aging Cell. 2004;3:3–6
  17. Del Priore LV, Kuo YH, Tezel TH. Age-related changes in human RPE cell density and apoptosis proportion in situ. Invest Ophthalmol Vis Sci. 2002;43:3312–3318
  18. Denton RM, Randle PJ, Bridges BJ, Cooper RH, Kerbey AL, Pask HT, et al. Regulation of mammalian pyruvate dehydrogenase. Mol Cell Biochem. 1975;9:27–53
  19. Dunaief JL, Dentchev T, Ying GS, Milam AH. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol. 2002;120:1435–1442
  20. Ershov AV, Bazan NG. Photoreceptor phagocytosis selectively activates PPARgamma expression in retinal pigment epithelial cells. J Neurosci Res. 2000;60:328–337
  21. Feher J, Papale A, Mannino G, Gualdi G, Balocco Gabrielei C. Mitotropic compounds for the treatment of age-related macular degeneration. The metabolic approach and a pilot study. Ophthalmologica. 2003;217:351–357
  22. Feher J, Kovacs B, Kovacs I, Schveoller M, Papale A, Balacco Gabrieli C. Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. Ophthalmologica. 2005;219:154–166
  23. Finnemann SC, Leung LW, Rodriguez-Boulan E. The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc Natl Acad Sci USA. 2002;99:3842–3847
  24. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA. 1997;94:4312–4317
  25. Fox DA, Poblenz AT, He L, Harris JB, Medrano CJ. Pharmacological strategies to block rod photoreceptor apoptosis caused by calcium overload: a mechanistic target-site approach to neuroprotection. Eur J Ophthalmol. 2003;13(Suppl 3):44–56
  26. Friedman DS, O’Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–572
  27. Furuno T, Kanno T, Arita K, Asami M, Utsumi T, Doi Y, et al. Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition. Biochem Pharmacol. 2001;62:1037–1046
  28. Gabbita SP, Subramaniam R, Allouch F, Carney JM, Butterfield DA. Effects of mitochondrial respiratory stimulation on membrane lipids and proteins: an electron paramagnetic resonance investigation. Biochim Biophys Acta. 1998;1372:163–173
  29. Gosker HR, Wouters EFM, van der Vusse GJ, Schols AMWJ. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr. 2000;71:1033–1047
  30. Haimovici R, Owens SL, Fitzke FW, Bird AC. Dark adaptation in age-related macular degeneration: relationship to the fellow eye. Arch Clin Exp Ophthalmol. 2002;240:90–95
  31. Hansson M, Ellis E, Hunt MC, Schmitz G, Babiker A. Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages. Biochim Biophys Acta. 2003;1593:283–289
  32. Hatch GM. Cell biology of cardiac mitochondrial phospholipids. Biochem Cell Biol. 2004;82:99–112
  33. Hettema EH, Tabak HF. Transport of fatty acids and metabolites across the peroxisomal membrane. Biochim Biophys Acta. 2000;1486:18–27
  34. Hiltunen JK, Qin Y. Beta-oxidation-strategies for the metabolism of a wide variety of acyl-CoA esters. Biochem Biophys Acta. 2000;1484:117–128
  35. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci. 2001;21:3017–3023
  36. Hollyfield JG, Salomon RG, Crabb JW. Proteomic approaches to understanding age-related macular degeneration. Adv Exp Med Biol. 2003;533:83–89
  37. Jackson GR, Owsley C, Curcio CA. Photoreceptor degeneration and dysfunction in aging and age-related maculopathy. Ageing Res Rev. 2002;1(3):381–396
  38. James AM, Murphy MP. How mitochondrial damage affects cell function. J Biomed Sci. 2002;9:475–487
  39. Jin GF, Hurst JS, Godley BF. Rod outer segments mediate mitochondrial DNA damage and apoptosis in human retinal pigment epithelium. Curr Eye Res. 2001;23:11–19
  40. Katz ML, Rice LM, Gao CL. Reversible accumulation of lipofuscin-like inclusions in the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1999;40:175–181
  41. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA. 1993;90:2160–2164
  42. Kennedy CJ, Rakoczy PE, Constable IJ. Lipofuscin of the retinal pigment epithelium: a review. Eye. 1995;9:763–771
  43. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51:2944–2950
  44. Kersten S, Desvergne B, Wahli W. Roles of PPARs in heath and disease. Nature. 2000;405:421–424
  45. Klaver CC, Wolfs RC, Vingerling JR, ofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116:653–658
  46. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA. 1997;94:4318–4323
  47. Kroemer G, Redd JC. Mitochondrial control of cell death. Nat Med. 2000;6:513–519
  48. Kuksa V, Imanishi Y, Batten M, Palczewski K, Moise AR. Retinoid cycle in the vertebrate retina: experimental approaches and mechanisms of isomerization. Vision Res. 2003;43:2959–2981
  49. Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res. 2003;76:397–403
  50. Marmorstein AD, Marmorstein LY, Sakaguchi H, Hollyfield JG. Spectral profiling of autofluorescence associated with lipofuscin, Bruch's membrane, and sub-RPE deposits in normal and AMD eyes. Invest Ophthalmol Vis Sci. 2002;43:2435–2441
  51. Midena E, Degli Angeli C, Blarzino MC, Valenti M, Segato T. Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci. 1997;38:469–477
  52. Murata T, He S, Hangai M, Ishibashi T, Xi XP, Kim S, et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Invest Ophthalmol Vis Sci. 2000;41(8):2309–2317
  53. Nagy L, Tontonoz P, Alvarez JGA, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. 1998;93:229–240
  54. Papadopoulo V. Peripheral benzodiazepine receptor: structure and function in health and disease. Ann Pharm Fr. 2003;61:30–50
  55. Paradies G, Ruggiero FM, Petrosillo G, Quagliariello E. Age-dependent decline in the cytochrome c oxidase activity in rat heart mitochondria: role of cardiolipin. FEBS Lett. 1997;406:136–138
  56. Pepe S, Tsuchiya N, Lakatta EG, Hansford RG. PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH. Am J Physiol. 1999;276:149–158
  57. Pepe S. Mitochondrial function in ischaemia and reperfusion of the ageing heart. Clin Exp Pharmacol Physiol. 2000;27:745–750
  58. Rakoczy PE, Zhang D, Robertson T, Barnett NL, Papadimitriou J, Constable IJ, et al. Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am J Pathol. 2002;16:1515–1524
  59. Remky A, Lichtenberg K, Elsner AE, Arend O. Short wavelength automated perimetry in age related maculopathy. Br J Ophthalmol. 2001;85:1432–1436
  60. Robison WG, Kuwabara T. Microperoxisomes in the retinal pigment epithelium. Invest Ophthalmol. 1975;14:866–872
  61. Rottenberg H, Wu S. Mitochondrial dysfunction in lymphocytes from old mice: enhanced activation of the permeability transition. Biochem Biophys Res Commun. 1997;240:68–74
  62. Shaban H, Borras C, Vina J, Richter C. Phosphatidylglycerol potently protects human retinal pigment epithelial cells against apoptosis induced by A2E, a compound suspected to cause age-related macula degeneration. Exp Eye Res. 2002;75:99–108
  63. Shamsi FA, Boulton M. Inhibition of the RPE lysosomal and antioxidant activity by the age pigment lipofuscin. Invest Ophthalmol Vis Sci. 2001;42:3041–3046
  64. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA. 1994;91:10771–10778
  65. Sparrow JR, Fishkin N, Zhou J, Cai B, Jang YP, Krane S, et al. A2E, a byproduct of the visual cycle. Vision Res. 2003;43:2983–2990
  66. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta. 2000;1486:219–231
  67. Schon EA, Manfredi G. Neuronal degeneration and mitochondrial dysfunction. J Clin Invest. 2003;111:303–312
  68. Sugrue MM, Tatton WG. Mitochondrial membrane potential in aging cells. Biol Signals Recept. 2001;10:176–188
  69. Sundelin S, Wihlmark U, Nilsson SE, Brunk UT. Lipofuscin accumulation in cultured retinal pigment epithelial cells reduces their phagocytic capacity. Curr Eye Res. 1998;17:851–857
  70. Suter M, Reme C, Grimm C, Wenzel A, Jaattela M, Esser P, et al. Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Biol Chem. 2000;275:39625–39630
  71. Szabo II, Adams C, Gulbins E. Ion channels and membrane rafts in apoptosis. Pflugers Arch. 2004;448:304–312Epub 2004 Apr 08
  72. Toescu EC, Myronova N, Verkhratsky A. Age-related structural and functional changes of brain mitochondria. Cell Calcium. 2000;28:329–338
  73. Tolentino MJ, Miller S, Gaudio AR, Sandberg MA. Visual field deficits in early age-related macular degeneration. Vision Res. 1994;34:409–413
  74. Tyni T, Johnson M, Eaton S, Pourfarzam M, Andrews R, Turnbull DM. Mitochondrial fatty acid beta-oxidation in the retinal pigment epithelium. Pediatr Res. 2002;52:595–600
  75. Varma R, Fraser-Bell S, Tan S, Klein R, Azen SP . Los Angeles Latino Eye Study Group. Prevalence of age-related macular degeneration in Latinos; The Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1288–1297
  76. von Ruckmann A, Schmidt KG, Fitzke FW, Bird AC, Jacobi KW. Dynamics of accumulation and degradation of lipofuscin in retinal pigment epithelium in senile macular degeneration. Klin Monatsbl Augenheilk. 1998;213:32–37
  77. Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vis. 1999;5:32;http://www.molvis.org/molvis/v5/p32/
  78. Wolf G. Lipofuscin and macular degeneration. Nutr Rev. 2003;61:342–346
  79. Zammit VA, Corstorphine CG, Kolodziej MP, Fraser F. Lipid molecular order in liver mitochondrial outer membranes, and sensitivity of carnitine palmitoyltransferase I to malonyl-CoA. Lipids. 1998;33:371–376
  80. Zingsheim HP, Plattner H. Electron microscopic methods in membrane biology. In:  Korn ED editors. Methods in membrane biology. New York: Plenum Press; 1976;p. 1–146

PII: S0197-4580(05)00154-5

doi: 10.1016/j.neurobiolaging.2005.05.012

Neurobiology of Aging
Volume 27, Issue 7 , Pages 983-993 , July 2006

Article Tools

* Image Usage & Resolution